Eli Lilly’s Foundayo (oral GLP 1) expands weight loss options The FDA has approved Eli Lilly’s new daily oral weight loss pill, Foundayo, giving patients an additional option besides injectable GLP 1 therapies such as Wegovy. The new medication matters because it targets the same market need that…
Continue reading...
Continue reading...